Kindstar Global Gene Technology
China's Advanced Gene Diagnostics
Wuhan, Hubei, China
Chinese specialty clinical testing provider partnering with BioState AI through joint venture. Operates a national clinical network of over 3,000 hospitals.
How We Help
Problem Statement
Kindstar Global addresses the critical need for advanced, comprehensive, and high-quality medical esoteric testing and diagnostic services in China, enabling more precise disease diagnosis, informed treatment decisions, and supporting scientific research.
Core Technology
Advanced laboratory platforms (flow cytometry, cytogenetics, medical genomics, molecular biology, hematopathology, mass spectrometry, pathology, clinical immunology, microbiology), gene editing technologies, molecular diagnostics platforms (e.g., ultra-multiplex PCR, potentially CRISPR-based systems), immunorepertoire technology, multi-omics, and AI integration.
Key Differentiators
Leading large-scale, high-end, independent medical esoteric testing service provider in China; extensive network serving over 3,000 hospitals; commitment to advanced technologies; strategic partnerships and investments; focus on precision medicine; high R&D investment; plans for multi-omics and AI integration.
Clinical Focus
Esoteric Testing, Clinical Diagnostics, Precision Medicine, Immunomedicine, Molecular Diagnostics
Target Customers
Hospitals, health systems, research institutions, pharmaceutical companies (CRO services)
Product Stage
Mature
Company Info
- Business Model
- B2B, Services, Investment Holding
- Founded
- 2003
- Total Funding
- 31,000,000
- Website
- en.kindstarglobal.com
Categories
Disease Areas
Technologies
MedStartr Index Score
?What do you think of Kindstar Global Gene Technology?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.